1. Home
  2. Bills
  3. H.R. 10628

H.R. 10628 · 119th Congress · 2025–2026

Biosimilars Access and Affordability Act

H.R. 10628 in the 119th Congress (2025–2026) was introduced on Sep 28, 2026, sponsored by Nicholas A. Langworthy with 8 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Introduced
Introduced
Sep 28, 2026
Co-sponsors
8
Policy area
Health

Sponsor

Nicholas A. Langworthy (R-NY). Co-sponsors: 5 Democrats, 3 Republicans.

Where it stands

  • IntroducedSep 28, 2026
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such (Sep 28, 2026)

More bills from Nicholas A. Langworthy in the 119th Congress

Other Health bills in the 119th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 10628 (119th Congress): Biosimilars Access and Affordability Act,” https://www.capitolreceipts.com/bill/119-hr-10628/biosimilars-access-and-affordability-act (accessed 2026-10-14).

Open the interactive version ›